Education
| Date | Speaker / Institution | Titel |
| 2008 | ||
| 17.01.2008 |
Prof. Ramiro Jover University of Valencia, Spain |
Regulation of human cytochrome P450 genes by liver-enriched transcription factors: Application to the development of metabolically competent hepatic cell models |
| 20.02.2008 |
PD Dr. Lütjohann University of Bonn |
Steroidal Marker of Cholesterol and Bile Acid Metabolism |
| 05.03.2008 |
Prof. Dr. Alfons Meindl University Hospital 'rechts der Isar', Munich |
Monogen, heterogen, polygen - Genetische Formen des familiären Mammakarzinoms |
| 29.04.2008 |
Prof V. Craig Jordan Fox Chase Cancer Center, Philadelphia, USA |
Development and Current Role of Tamoxifen and Raloxifen in the Treatment or Prevention of Breast Cancer and Osteoporosis |
| 11.06.2008 |
Dr. Hajo Otten, Patent Lawyer Witte, Welle & Partner, Stuttgart |
Patente und geistiges Eigentum in Medizin und Biotechnologie - eine Einführung |
| 24.06.2008 |
Prof. Dr. Werner Lubitz Universitäy of Vienna, Austra |
Bacterial Ghost Platform Technology |
| 09.07.2008 |
Prof. Jens Schröder University of Schleswig-Holstein |
Antimicrobial Peptides: Local Host Response Elements |
| 17.07.2008 |
Dr. Rene Krieg Bruker Daltronik GmbH |
MALDI Imaging, Molecular Histology and Class Imaging – Novel Techniques for Tissue Based Proteomics |
| 18.07.2008 |
Prof. Paavo Honkakosi University of Kuopio, Finland |
Unraveling the ligand specificity of nuclear receptor CAR |
| 09.09.2008 |
Prof. Lutz Heide University of Tübingen |
Genetic engineering of microorganisms for the generation of new antibiotics |
| 15.09.2008 |
Dr. Jörg Lippert Bayer Technology Services GmbH |
Mechanistische Modellierung und Ihre Anwendungen in der klinischen Pharmakologie |
| 29.09.2008 |
Professor Amin Rostami-Hodjegan University of Sheffield, UK |
Systems Pharmacology: Putting Things Together |
| 10.10.2008 |
Prof. Jose Pedro Gil Karolinska Institute, Sweden |
Artemisin derivative combination therapy – a malaria chemotherapy under global implementation |
| 17.10.2008 |
Prof. Meinhard Kieser University Hospital Heidelberg |
Fallzahlberechnung unter Unsicherheit - Welche Möglichkeiten bieten flexible Studiendesigns? |
| 2009 | ||
| 28.01.2009 |
Prof. Dr. med. Martin Wehling University Hospital Mannheim |
Nutzenanalyse in Deutschland: Götterdämmerung oder weiter so? |
| 29.01.2009 |
Univ.-Prof. Dr. med. Karsten Schrör University Hospital Düsseldorf |
Pharmakokinetik und Antiplättchenwirkung von Thienopyridine |
| 23.03.2009 |
Prof. Dr. med. Martina Muckenthaler University Hospital Heidelberg |
Regulation of systemic iron homeostasis by miR122a |
| 05.05.2009 |
Prof. Michael S. Phillips, Ph.D Université de Montréal |
Development and optimization of a broad-based ADME genotyping system in clinical trials |
| 12.05.2009 |
Dr. med. Lusine Danielyan University Hospital Tübingen |
Intranasal delivery of cells to the brain |
| 26.10.2009 |
Dr. med. Andreas Benesic Prof. Dr. Alexander L. Gerbes University Hospital Munich Großhadern |
Metaheps - interessante Zellen aus peripheren Monozyten |
| 29.10.2009 |
Dr. Jan Korbel European Molecular Biology Laboratory, Heidelberg |
Global mapping of coy-number variants in humans - approaches and applications |
| 10.12.2009 |
Dr. Carole Devaux, Ph.D. University of Luxembourg |
Collaboration with Africa for HIV and AIDS: Challenges and Opportunities |
| 2010 | ||
| 08.03.2010 |
Dr. Carina Hellberg Ludwig Institute for Cancer Research, Uppsala, Sweden |
T-cell protein tyrosie phophatase regulates the M2 pyruvate kinase activity. |
| 31.03.2010 |
Dr.-Ing Jürgen Friedmann Vice-President Corporate Intellectual Property Patents Electronics, Robert Bosch GmbH |
Von der Idee zum Patent |
| 27.05.2010 |
Dr. Manfred Rauh University Hospital Erlangen |
LC-MS/MS in der Steroidanalytik |